MED7 Antikörper
-
- Target Alle MED7 Antikörper anzeigen
- MED7 (Mediator Complex Subunit 7 (MED7))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser MED7 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Flow Cytometry (FACS)
- Aufreinigung
- This antibody is purified through a protein A column, followed by peptide affinity purification.
- Immunogen
- Human MED7.
- Isotyp
- IgG
- Top Product
- Discover our top product MED7 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS with 0.09 % (W/V) sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.
-
- Target
- MED7 (Mediator Complex Subunit 7 (MED7))
- Andere Bezeichnung
- MED7 (MED7 Produkte)
- Synonyme
- ARC34 antikoerper, CRSP33 antikoerper, CRSP9 antikoerper, 1110063B05Rik antikoerper, Crsp33 antikoerper, Crsp9 antikoerper, crsp9 antikoerper, wu:fd99d12 antikoerper, zgc:56241 antikoerper, crsp9-A antikoerper, med7-a antikoerper, mediator complex subunit 7 antikoerper, mediator complex subunit 7 L homeolog antikoerper, mediator complex subunit antikoerper, mediator complex subunit Med7 antikoerper, MED7 antikoerper, Med7 antikoerper, med7 antikoerper, med7.L antikoerper
- UniProt
- O43513
- Pathways
- Stem Cell Maintenance, Regulation of Lipid Metabolism by PPARalpha
-